Search Results

Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.

• Authors : Kotterba S; Klinik für Geriatrie, Klinikum Leer gemeinnützige GmbH, Leer, Germany.; Neusser T

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use ; Interferon beta-1b/Interferon beta-1b/Interferon beta-1b/*therapeutic use ; Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/*drug therapy

• Source: BMC neurology [BMC Neurol] 2018 Aug 24; Vol. 18 (1), pp. 123. Date of Electronic Publication: 2018 Aug 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.

• Authors : Kleiter I; St. Josef Hospital, University Hospital Bochum, Bochum, Germany.; Present Address: Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany.

Subjects: Medication Adherence*; Interferon beta-1b/Interferon beta-1b/Interferon beta-1b/*administration & dosage ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*drug therapy

• Source: BMC neurology [BMC Neurol] 2017 Sep 06; Vol. 17 (1), pp. 174. Date of Electronic Publication: 2017 Sep 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.

• Authors : Hoffmann FA; Department of Neurology, Hospital Martha-Maria Halle-Dölau, Halle, Germany.; Trenova A

Subjects: Patient Satisfaction*; Interferon beta-1b/Interferon beta-1b/Interferon beta-1b/*therapeutic use ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*drug therapy

• Source: BMC neurology [BMC Neurol] 2017 Aug 09; Vol. 17 (1), pp. 156. Date of Electronic Publication: 2017 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study.

• Authors : Patti, Francesco¹ (AUTHOR) ; Penaherrera, Javier Nicolas² (AUTHOR); Zieger, Lorissa^3,4 (AUTHOR)

Subjects: *INTERFERON beta 1b; *OLDER patients; *OLDER people

• Source: BMC Neurology. 8/23/2021, Vol. 21 Issue 1, p1-9. 9p.

Record details

Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.

• Authors : Zettl, Uwe Klaus¹; Bauer-Steinhusen, Ulrike²; Glaser, Thomas²

Subjects: *MULTIPLE sclerosis; *INTERFERON beta 1b; *DEMYELINATION

• Source: BMC Neurology. 9/21/2016, Vol. 16, p1-7. 7p. 2 Charts, 2 Graphs.

Record details

Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.

• Authors : Zettl, Uwe K.; Bauer-Steinhusen, Ulrike; Glaser, Thomas

Subjects: ELECTRONIC data processing; INTERFERONS; PATIENT compliance

• Source: BMC Neurology; 2013, Vol. 13 Issue 1, p1-9, 9p, 1 Color Photograph, 1 Diagram, 6 Charts, 2 Graphs

Record details

Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis.

• Authors : Ross, Amy Perrin; Nicholas, Jacqueline; Tai, Ming-Hui

Subjects: PATIENT satisfaction; PATIENT experience; SATISFACTION

• Source: BMC Neurology; 1/20/2025, Vol. 25 Issue 1, p1-10, 10p

Record details

Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies.

• Authors : Zivadinov, Robert; Keenan, Alexander J.; Le, Hoa H.

Subjects: MAGNETIC resonance imaging; MAGNETOTHERAPY; RANDOMIZED controlled trials

• Source: BMC Neurology; 10/8/2024, Vol. 24 Issue 1, p1-12, 12p

Record details

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.

• Authors : Calkwood, Jonathan; Cree, Bruce; Crayton, Heidi

• Source: BMC Neurology; 2014, Vol. 14 Issue 1, p220-230, 11p, 2 Charts, 6 Graphs

Record details

Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis.

• Authors : Saida, Takahiko; Hao, Qi; Kanda, Michihiro

Subjects: JAPANESE people; NATALIZUMAB; MULTIPLE sclerosisJAPAN

• Source: BMC Neurology; 8/29/2023, Vol. 23 Issue 1, p1-10, 10p

Record details